WHC is still in active development. Read this to understand our approach.
depiction of AIVSIRYZIBXTMM-UHFFFAOYSA-N.svg
tripsit

ethylphenidate

Verificar en tripsit

psychonaut

Ethylphenidate

Verificar en psychonaut

isomerdesign

EPH

Verificar en isomerdesign

druglab

Ethylphénidate

Verificar en druglab

wiki

Ethylphenidate

Verificar en wiki

Data

InChI: InChI=1S/C15H21NO2/c1-2-18-15(17)14(12-8-4-3-5-9-12)13-10-6-7-11-16-13/h3-5,8-9,13-14,16H,2,6-7,10-11H2,1H3

Sinónimos: EPH,DTXSID60912317,(2R,2''R)-Phenyl-piperidin-2-yl-acetic acid ethyl ester; hydrochloride,Ethylphenidate,2-Piperidineacetic acid, alpha-phenyl-, ethyl ester,ethyl phenyl(piperidin-2-yl)acetate,eph,SCHEMBL727938,57413-43-1,CHEMBL1187932,ethyl 2-phenyl-2-piperidin-2-ylacetate,BDBM50165211,Phenyl-piperidin-2-yl-acetic acid ethyl ester; hydrochloride,CHEMBL534479,(2S,2''S)-Phenyl-piperidin-2-yl-acetic acid ethyl ester; hydrochloride,AKOS025149438,Q5404506,Ethyl-2-phenyl-2-(2-piperidyl)acetate,EP

Market name: ethylphenidate

Estimated data

Solubilidad: -2.651 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 95.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.